IU Health has been pushing in recent months to build its in-house team of neurosurgeons and will end its relationship in December with Goodman Campbell, which has provided a big part of neurosurgery services at hospitals and the medical school for the past nine years.
Two out-of-state companies that want to build a 60-bed hospital in Carmel have a history of mass layoffs, at least one high-profile bankruptcy, and accusations of kickbacks and billing irregularities.
The Indianapolis-based drugmaker has updated the label on Verzenio with a new warning after Japanese health officials said the drug is suspected of adversely affecting patients’ lungs.
A federal grand jury indicted Brian Fenner of Indianapolis, and a partner, Dennis Birkey of Wisconsin, in an alleged scheme to fraudulently take title to other people's cars and then sell them for their own profit.
Infrastructure & Energy Alternatives Inc. chalked up the loss to several expensive acquisitions and the cost of finishing projects delayed by weather.
The Indiana Family & Social Services Administration says the plan is designed to help bridge the transition from the Healthy Indiana Plan to private health insurance, and help pay for premiums, deductibles, co-pays and other costs.
The cost of Indiana environmental permits on everything from incinerators to wastewater-treatment plants is just a fraction of what nearby states charge.
One of the project’s partners, Post Acute Medical LLC of Pennsylvania, has been shutting down hospitals in Texas and Wisconsin in recent months.
Prosecutors said Chinese resident Fujie Wang and a person they call John Doe were behind the huge data breach at the Indianapolis-based insurer in 2015, which compromised the information of 78 million people.
The Rand Corp. study, which examined nearly 1,600 hospitals in 25 states, found that Indiana prices are the highest compared with Medicare fees.
Backed by more than $100 million in funding from Indiana companies and foundations, the Indiana Biosciences Research Institute has hired 39 employees and hopes to ramp up to 80 within another three years.
The Indianapolis-based company also announced a deal to cover nearly 4,000 government workers and dependents in Hamilton County, Ohio.
Endocyte Inc.'s decision two years ago to shelve its own pipeline and look for other opportunities was a difficult call that eventually paid off for investors, its former CEO said Friday at IBJ’s Life Sciences Power Breakfast.
Caprice R. Bearden, the company’s former compliance officer, pleaded guilty in November to multiple criminal charges related to the sale of over-potent drugs. She later testified against her boss, who was convicted and awaits sentencing.
This month, Saxton took on an additional position—vice president for business development at Regenstrief Institute, a medical-research organization based in Indianapolis.
The city’s newest park is springing up on the south side of downtown, a district quickly filling up with apartments, offices and retail—and a noticeable shortage of public green space.
The utility had wanted to build the gas-fired plant to replace aging coal-burning units, but regulators said the plan was too risky and inflexible.
The two sides seem to be digging in as a deadline approaches for them to figure out a way to work together after the end of this year.
Long a leader in diabetes and neuroscience drugs, Eli Lilly and Co. is pushing hard and spending record sums to turbocharge its oncology business, potentially a huge growth area.
Dr. Rainer Fischer is giving up the roles of CEO and chief scientific officer, but will continue as senior executive for innovation and discovery.
